Skip to content
Subscription

Get Experience Life delivered to your door

current issue of Experience Life
Delivered every two months

Real Health. No Hype.

More than 600,000 subscribers trust us to keep them informed, inspired, and authentically healthy. Join them.

PUMPING IRONY: Genetics and a Pharmaceutical Puzzle

Can your genetic profile affect your body’s response to certain medications? A new study offers some clues — and reveals some conundrums.

medical illustration

When the blockage in my arteries persuaded me a few years back to begin taking a statin, my doctor noted that I should also avoid my preferred breakfast beverage, grapefruit juice, as it was known to produce some unwanted side effects among people taking the drug. I dutifully switched to orange juice but soon experienced mysterious episodes of peripheral neuropathy.

I replaced my atorvastatin prescription with one for rosuvastatin, but the neuropathic episodes have continued. My doctor suggests it may have more to do with the arthritis in my neck than with the statin. But who knows? Pharmaceutical solutions are seldom as straightforward as we would prefer. Medications may interact with each other in harmful ways, specific health conditions may lead to unforeseen side effects, and recent research suggests that even our genetic profile may influence how we respond to certain drugs.

The genetic factor is a puzzle that physicians and pharmacists often struggle to solve, notes Philip Empey, PharmD, PhD, an associate professor at the University of Pittsburgh School of Pharmacy. He led a recent study showing that people carrying specific genes reported harmful side effects when taking certain medications. And nearly one in four of those study participants were prescribed a drug despite carrying a gene known to affect its performance.

“Many people have experience with taking a medication that is not working well for them or that has a side effect,” Empey says. “While many things impact how a patient responds to medication, our research tells us that genetics could be a factor for a large proportion of patients, and it points to the value of precision medicine in prescribing.”

The study, published last week in Science Translational Medicine, analyzed data from nearly 100,000 people who participated in the National Institute of Health’s All of Us research program. Reviewing their medical records, researchers identified the various medications they used and the genes they carried. The team focused on the variants in 16 genes known to influence the effectiveness of those drugs and found that each participant carried at least one variant of the selected genes and, on average, hosted nine of them.

Comparing medication usage and genetic data, researchers discovered that 24.4 percent of the cohort had been prescribed at least one drug despite carrying a variant known to affect the medication’s performance. The most common medications researchers identified were ondansetron (an antinausea drug), ibuprofen (anti-inflammatory), omeprazole and pantoprazole (acid reflux and heartburn), and . . . atorvastatin.

Empey points out that some 300 prescription drugs currently feature labeling that alerts patients carrying particular genetic variants about potential side effects. He cites a chemotherapy drug used in colon cancer treatment, for instance, that has been shown to produce toxic side effects in as many as 8 percent of patients carrying a particular genetic variant. As a result, physicians typically review the genetic profile of those who are prescribed such treatment before beginning the regimen.

As helpful as such data may be, however, Empey admits that our healthcare system is not currently equipped to facilitate such a genetic review. Pharmacogenomic screenings, designed to identify harmful gene–drug interactions, are generally not covered by insurance. And it’s questionable whether the typical patient is conversant enough about the benefits and liabilities of such a test to even raise the question with their doctor or pharmacist.

“Just like with any new technology, it comes down to responsible implementation,” he says. “Costs are coming down and the data is increasing, so it is important for patients and clinicians to be aware that the use of precision medicine in prescribing is becoming commonplace.”

Empey’s findings may offer some fresh insights into the murky art of pharmacology, and it may even steer a few patients toward a more effective medication regimen. But, if I’ve learned anything during my own pharmaceutical journey, it’s that the human body is exceedingly complicated and often resists simple solutions — regardless of their perceived elegance.

My genetic profile remains a mystery to me. I assume that it wasn’t some variant that produced the neuropathic response to my atorvastatin regimen, because it persisted when I swapped it for another drug. But who knows? Maybe I carry a variant that doesn’t get along with that drug either. Or maybe it is the arthritis in my neck, or some manifestation of prediabetes, or simply another case of random cellular mischief. Healthcare is really more of an exercise in trial and error than I had ever imagined.

There is one other thing I hadn’t considered: Maybe I never should’ve abandoned the grapefruit juice.

Craig Cox

Craig Cox is an Experience Life deputy editor who explores the joys and challenges of healthy aging.

Share

More like this

PUMPING IRONY: A Proliferation of Pills

I’m beginning to understand why seniors tend to take so many medications and why all those drugs can create unforeseeable consequences.
By Craig Cox

PUMPING IRONY: A Tough Pill to Swallow

The Inflation Reduction Act will make some prescription drugs much more affordable for strapped Medicare beneficiaries. But will it deepen our dependence on Big Pharma?
By Craig Cox

Share a thought

0 Comments

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep the conversation going

Leave a comment, ask a question, or see what others are talking about in the Life Time Health Facebook group.

Facebook Group

Advertisement

Back To Top